Your browser doesn't support javascript.
loading
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall, Sebastian; Ng, Henry; Jernbom Falk, August; Greilert-Norin, Nina; Månberg, Anna; Marking, Ulrika; Laurén, Ida; Gabrielsson, Lena; Salomonsson, Ann-Christin; Aguilera, Katherina; Kihlgren, Martha; Månsson, Maja; Rosell, Axel; Hellström, Cecilia; Andersson, Eni; Olofsson, Jennie; Skoglund, Lovisa; Yousef, Jamil; Pin, Elisa; Lord, Martin; Åberg, Mikael; Hedhammar, My; Tegel, Hanna; Dönnes, Pierre; Phillipson, Mia; Nilsson, Peter; Klingström, Jonas; Mangsbo, Sara; Hober, Sophia; Thålin, Charlotte.
Afiliación
  • Havervall S; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Ng H; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Jernbom Falk A; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Greilert-Norin N; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Månberg A; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Marking U; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Laurén I; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Gabrielsson L; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Salomonsson AC; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Aguilera K; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Kihlgren M; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Månsson M; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Rosell A; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Hellström C; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Andersson E; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Olofsson J; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Skoglund L; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Yousef J; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Pin E; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Lord M; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Åberg M; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Hedhammar M; Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Tegel H; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Dönnes P; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Phillipson M; SciCross AB, Skövde, Sweden.
  • Nilsson P; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Klingström J; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Mangsbo S; Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Hober S; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Thålin C; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
J Intern Med ; 291(1): 72-80, 2022 01.
Article en En | MEDLINE | ID: mdl-34459525
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunidad Humoral / Reinfección / COVID-19 / Inmunidad Celular / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunidad Humoral / Reinfección / COVID-19 / Inmunidad Celular / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido